TY - JOUR AU - Siegel, R. AU - Naishadham, D. AU - Jemal, A. PY - 2013 DA - 2013// TI - Cancer statistics, 2013 JO - CA Cancer J Clin VL - 63 UR - https://doi.org/10.3322/caac.21166 DO - 10.3322/caac.21166 ID - Siegel2013 ER - TY - STD TI - Cancer Incidence in Five Continents. Volume IX. Geneva, Switzerland: WHO Press. IARC scientific publications 2008(160):1–837. ID - ref2 ER - TY - JOUR AU - Volanis, D. AU - Kadiyska, T. AU - Galanis, A. AU - Delakas, D. AU - Logotheti, S. AU - Zoumpourlis, V. PY - 2010 DA - 2010// TI - Environmental factors and genetic susceptibility promote urinary bladder cancer JO - Toxicol Lett VL - 193 UR - https://doi.org/10.1016/j.toxlet.2009.12.018 DO - 10.1016/j.toxlet.2009.12.018 ID - Volanis2010 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2000 DA - 2000// TI - The hallmarks of cancer JO - Cell VL - 100 UR - https://doi.org/10.1016/S0092-8674(00)81683-9 DO - 10.1016/S0092-8674(00)81683-9 ID - Hanahan2000 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Coussens, L. M. AU - Werb, Z. PY - 2002 DA - 2002// TI - Inflammation and cancer JO - Nature VL - 420 UR - https://doi.org/10.1038/nature01322 DO - 10.1038/nature01322 ID - Coussens2002 ER - TY - JOUR AU - Ohshima, H. AU - Tatemichi, M. AU - Sawa, T. PY - 2003 DA - 2003// TI - Chemical basis of inflammation-induced carcinogenesis JO - Arch Biochem Biophys VL - 417 UR - https://doi.org/10.1016/S0003-9861(03)00283-2 DO - 10.1016/S0003-9861(03)00283-2 ID - Ohshima2003 ER - TY - JOUR AU - Balkwill, F. AU - Charles, K. A. AU - Mantovani, A. PY - 2005 DA - 2005// TI - Smoldering and polarized inflammation in the initiation and promotion of malignant disease JO - Cancer Cell VL - 7 UR - https://doi.org/10.1016/j.ccr.2005.02.013 DO - 10.1016/j.ccr.2005.02.013 ID - Balkwill2005 ER - TY - JOUR AU - Karin, M. PY - 2006 DA - 2006// TI - Nuclear factor-kappaB in cancer development and progression JO - Nature VL - 441 UR - https://doi.org/10.1038/nature04870 DO - 10.1038/nature04870 ID - Karin2006 ER - TY - JOUR AU - Lin, W. W. AU - Karin, M. PY - 2007 DA - 2007// TI - A cytokine-mediated link between innate immunity, inflammation, and cancer JO - J Clin Invest VL - 117 UR - https://doi.org/10.1172/JCI31537 DO - 10.1172/JCI31537 ID - Lin2007 ER - TY - JOUR AU - Michaud, D. S. PY - 2007 DA - 2007// TI - Chronic inflammation and bladder cancer JO - Urol Oncol VL - 25 UR - https://doi.org/10.1016/j.urolonc.2006.10.002 DO - 10.1016/j.urolonc.2006.10.002 ID - Michaud2007 ER - TY - JOUR AU - Saito, K. AU - Kihara, K. PY - 2011 DA - 2011// TI - C-reactive protein as a biomarker for urological cancers JO - Nat Rev Urol VL - 8 ID - Saito2011 ER - TY - JOUR AU - Stein, B. AU - Schrader, A. J. AU - Wegener, G. AU - Seidel, C. AU - Kuczyk, M. A. AU - Steffens, S. PY - 2013 DA - 2013// TI - Preoperative serum C- reactive protein: a prognostic marker in patients with upper urinary tract urothelial carcinoma JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-101 DO - 10.1186/1471-2407-13-101 ID - Stein2013 ER - TY - JOUR AU - Hilmy, M. AU - Bartlett, J. M. AU - Underwood, M. A. AU - McMillan, D. C. PY - 2005 DA - 2005// TI - The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder JO - Br J Cancer VL - 92 UR - https://doi.org/10.1038/sj.bjc.6602406 DO - 10.1038/sj.bjc.6602406 ID - Hilmy2005 ER - TY - JOUR AU - Kastelein, R. A. AU - Hunter, C. A. AU - Cua, D. J. PY - 2007 DA - 2007// TI - Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation JO - Annu Rev Immunol VL - 25 UR - https://doi.org/10.1146/annurev.immunol.22.012703.104758 DO - 10.1146/annurev.immunol.22.012703.104758 ID - Kastelein2007 ER - TY - JOUR AU - Hunter, C. A. AU - Kastelein, R. PY - 2012 DA - 2012// TI - Interleukin-27: balancing protective and pathological immunity JO - Immunity VL - 37 UR - https://doi.org/10.1016/j.immuni.2012.11.003 DO - 10.1016/j.immuni.2012.11.003 ID - Hunter2012 ER - TY - JOUR AU - Pflanz, S. AU - Timans, J. C. AU - Cheung, J. AU - Rosales, R. AU - Kanzler, H. AU - Gilbert, J. PY - 2002 DA - 2002// TI - IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells JO - Immunity VL - 16 UR - https://doi.org/10.1016/S1074-7613(02)00324-2 DO - 10.1016/S1074-7613(02)00324-2 ID - Pflanz2002 ER - TY - JOUR AU - Wojno, E. D. AU - Hunter, C. A. PY - 2012 DA - 2012// TI - New directions in the basic and translational biology of interleukin-27 JO - Trends Immunol VL - 33 UR - https://doi.org/10.1016/j.it.2011.11.003 DO - 10.1016/j.it.2011.11.003 ID - Wojno2012 ER - TY - JOUR AU - Stumhofer, J. S. AU - Hunter, C. A. PY - 2008 DA - 2008// TI - Advances in understanding the anti-inflammatory properties of IL-27 JO - Immunol Lett VL - 117 UR - https://doi.org/10.1016/j.imlet.2008.01.011 DO - 10.1016/j.imlet.2008.01.011 ID - Stumhofer2008 ER - TY - JOUR AU - Awasthi, A. AU - Carrier, Y. AU - Peron, J. P. AU - Bettelli, E. AU - Kamanaka, M. AU - Flavell, R. A. PY - 2007 DA - 2007// TI - A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells JO - Nat Immunol VL - 8 UR - https://doi.org/10.1038/ni1541 DO - 10.1038/ni1541 ID - Awasthi2007 ER - TY - JOUR AU - Murugaiyan, G. AU - Saha, B. PY - 2013 DA - 2013// TI - IL-27 in tumor immunity and immunotherapy JO - Trends Mol Med VL - 19 UR - https://doi.org/10.1016/j.molmed.2012.12.002 DO - 10.1016/j.molmed.2012.12.002 ID - Murugaiyan2013 ER - TY - JOUR AU - Swarbrick, A. AU - Junankar, S. R. AU - Batten, M. PY - 2013 DA - 2013// TI - Could the properties of IL-27 make it an ideal adjuvant for anticancer immunotherapy? JO - Oncoimmunology VL - 2 UR - https://doi.org/10.4161/onci.25409 DO - 10.4161/onci.25409 ID - Swarbrick2013 ER - TY - STD TI - Xu M, Mizoguchi I, Morishima N, Chiba Y, Mizuguchi J, Yoshimoto T: Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. Clin Dev Immunol 2010, 2010. ID - ref23 ER - TY - JOUR AU - Hisada, M. AU - Kamiya, S. AU - Fujita, K. AU - Belladonna, M. L. AU - Aoki, T. AU - Koyanagi, Y. PY - 2004 DA - 2004// TI - Potent antitumor activity of interleukin-27 JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-2084 DO - 10.1158/0008-5472.CAN-03-2084 ID - Hisada2004 ER - TY - JOUR AU - Shimizu, M. AU - Shimamura, M. AU - Owaki, T. AU - Asakawa, M. AU - Fujita, K. AU - Kudo, M. PY - 2006 DA - 2006// TI - Antiangiogenic and antitumor activities of IL-27 JO - J Immunol VL - 176 UR - https://doi.org/10.4049/jimmunol.176.12.7317 DO - 10.4049/jimmunol.176.12.7317 ID - Shimizu2006 ER - TY - JOUR AU - Huang, N. AU - Liu, L. AU - Wang, X. Z. AU - Liu, D. AU - Yin, S. Y. AU - Yang, X. D. PY - 2008 DA - 2008// TI - Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population JO - DNA Cell Biol VL - 27 UR - https://doi.org/10.1089/dna.2007.0715 DO - 10.1089/dna.2007.0715 ID - Huang2008 ER - TY - JOUR AU - Chae, S. C. AU - Li, C. S. AU - Kim, K. M. AU - Yang, J. Y. AU - Zhang, Q. AU - Lee, Y. C. PY - 2007 DA - 2007// TI - Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population JO - J Hum Genet VL - 52 UR - https://doi.org/10.1007/s10038-007-0123-8 DO - 10.1007/s10038-007-0123-8 ID - Chae2007 ER - TY - JOUR AU - Li, C. S. AU - Zhang, Q. AU - Lee, K. J. AU - Cho, S. W. AU - Lee, K. M. AU - Hahm, K. B. PY - 2009 DA - 2009// TI - Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population JO - J Gastroenterol Hepatol VL - 24 UR - https://doi.org/10.1111/j.1440-1746.2009.05901.x DO - 10.1111/j.1440-1746.2009.05901.x ID - Li2009 ER - TY - JOUR AU - Huang, Z. Q. AU - Wang, J. L. AU - Pan, G. G. AU - Wei, Y. S. PY - 2012 DA - 2012// TI - Association of single nucleotide polymorphisms in IL-12 and IL-27 genes with colorectal cancer risk JO - Clin Biochem VL - 45 UR - https://doi.org/10.1016/j.clinbiochem.2011.10.004 DO - 10.1016/j.clinbiochem.2011.10.004 ID - Huang2012 ER - TY - JOUR AU - Tao, Y. P. AU - Wang, W. L. AU - Li, S. Y. AU - Zhang, J. AU - Shi, Q. Z. AU - Zhao, F. PY - 2012 DA - 2012// TI - Associations between polymorphisms in IL-12A, IL-12B, IL-12Rbeta1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer JO - J Cancer Res Clin Oncol VL - 138 UR - https://doi.org/10.1007/s00432-012-1269-0 DO - 10.1007/s00432-012-1269-0 ID - Tao2012 ER - TY - JOUR AU - Zhao, B. AU - Meng, L. Q. AU - Huang, H. N. AU - Pan, Y. AU - Xu, Q. Q. PY - 2009 DA - 2009// TI - A novel functional polymorphism, 16974 A/C, in the interleukin-12-3′ untranslated region is associated with risk of glioma JO - DNA Cell Biol VL - 28 UR - https://doi.org/10.1089/dna.2008.0845 DO - 10.1089/dna.2008.0845 ID - Zhao2009 ER - TY - STD TI - Hu T, Zhao H, Wang K, Sun W, Li L, Wang W: Association of IL-27 polymorphisms and cancer risk in Chinese population. J Recept Signal Transduct Res 2015;35(2):180–3. ID - ref32 ER - TY - STD TI - Xu XP, Hua LY, Chao HL, Chen ZX, Wang XF, Ji J, et al. Genetic association between IL-27 rs153109 polymorphism and cancer risk in Chinese population: a meta-analysis. J Recept Signal Transduct Res 2014:1–6. ID - ref33 ER - TY - JOUR AU - Ke, X. AU - Collins, A. AU - Ye, S. PY - 2001 DA - 2001// TI - PIRA PCR designer for restriction analysis of single nucleotide polymorphisms JO - Bioinformatics VL - 17 UR - https://doi.org/10.1093/bioinformatics/17.9.838 DO - 10.1093/bioinformatics/17.9.838 ID - Ke2001 ER - TY - JOUR AU - Sole, X. AU - Guino, E. AU - Valls, J. AU - Iniesta, R. AU - Moreno, V. PY - 2006 DA - 2006// TI - SNPStats: a web tool for the analysis of association studies JO - Bioinformatics VL - 22 UR - https://doi.org/10.1093/bioinformatics/btl268 DO - 10.1093/bioinformatics/btl268 ID - Sole2006 ER - TY - JOUR AU - Devergne, O. AU - Hummel, M. AU - Koeppen, H. AU - Beau, M. M. AU - Nathanson, E. C. AU - Kieff, E. PY - 1996 DA - 1996// TI - A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes JO - J Virol VL - 70 ID - Devergne1996 ER - TY - JOUR AU - Hall, A. O. AU - Silver, J. S. AU - Hunter, C. A. PY - 2012 DA - 2012// TI - The immunobiology of IL-27 JO - Adv Immunol VL - 115 UR - https://doi.org/10.1016/B978-0-12-394299-9.00001-1 DO - 10.1016/B978-0-12-394299-9.00001-1 ID - Hall2012 ER - TY - JOUR AU - Salcedo, R. AU - Stauffer, J. K. AU - Lincoln, E. AU - Back, T. C. AU - Hixon, J. A. AU - Hahn, C. PY - 2004 DA - 2004// TI - IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells JO - J Immunol VL - 173 UR - https://doi.org/10.4049/jimmunol.173.12.7170 DO - 10.4049/jimmunol.173.12.7170 ID - Salcedo2004 ER - TY - JOUR AU - Zhao, H. AU - Zhang, Y. AU - Xue, F. AU - Xu, J. AU - Fang, Z. PY - 2013 DA - 2013// TI - Interleukin-27 rs153109 polymorphism and the risk for immune thrombocytopenia JO - Autoimmunity VL - 46 UR - https://doi.org/10.3109/08916934.2013.822072 DO - 10.3109/08916934.2013.822072 ID - Zhao2013 ER - TY - JOUR AU - Wei, Y. S. AU - Lan, Y. AU - Luo, B. AU - Lu, D. AU - Nong, H. B. PY - 2009 DA - 2009// TI - Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma JO - Mol Carcinog VL - 48 UR - https://doi.org/10.1002/mc.20522 DO - 10.1002/mc.20522 ID - Wei2009 ER - TY - STD TI - Zhang Z, Zhou B, Wu Y, Gao Q, Zhang K, Song Y, et al. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population. Immunogenetics. 2014;66(2):85–92. ID - ref41 ER - TY - JOUR AU - Santos, A. S. AU - Melo, M. E. AU - Crisostomo, L. G. AU - Fukui, R. T. AU - Matioli, S. R. AU - Silva, M. E. PY - 2013 DA - 2013// TI - Lack of association between IL27 gene variants and type 1 diabetes susceptibility JO - Cytokine VL - 61 UR - https://doi.org/10.1016/j.cyto.2012.12.003 DO - 10.1016/j.cyto.2012.12.003 ID - Santos2013 ER - TY - JOUR AU - Miyagaki, T. AU - Sugaya, M. AU - Shibata, S. AU - Ohmatsu, H. AU - Fujita, H. AU - Tamaki, K. PY - 2010 DA - 2010// TI - Serum interleukin-27 levels in patients with cutaneous T-cell lymphoma JO - Clin Exp Dermatol VL - 35 UR - https://doi.org/10.1111/j.1365-2230.2009.03684.x DO - 10.1111/j.1365-2230.2009.03684.x ID - Miyagaki2010 ER - TY - JOUR AU - Li, H. Y. AU - Zhang, D. L. AU - Ge, J. AU - Zhou, H. AU - Qi, A. AU - Ma, L. PY - 2012 DA - 2012// TI - Elevated interleukin-27 enhances the polarization of Th1/Tc1 cells and the production of proinflammatory cytokines in primary immune thrombocytopenia JO - Hum Immunol VL - 73 UR - https://doi.org/10.1016/j.humimm.2011.12.010 DO - 10.1016/j.humimm.2011.12.010 ID - Li2012 ER - TY - JOUR AU - Diakowska, D. AU - Lewandowski, A. AU - Markocka-Maczka, K. AU - Grabowski, K. PY - 2013 DA - 2013// TI - Concentration of serum interleukin-27 increase in patients with lymph node metastatic gastroesophageal cancer JO - Adv Clin Exp Med VL - 22 ID - Diakowska2013 ER - TY - JOUR AU - Zolochevska, O. AU - Ellis, J. AU - Parelkar, S. AU - Chan-Seng, D. AU - Emrick, T. AU - Wei, J. PY - 2013 DA - 2013// TI - Interleukin-27 gene delivery for modifying malignant interactions between prostate tumor and bone JO - Hum Gene Ther VL - 24 UR - https://doi.org/10.1089/hum.2013.091 DO - 10.1089/hum.2013.091 ID - Zolochevska2013 ER -